Individualized genetic makeup that controls natural killer cell function influences the efficacy of isatuximab immunotherapy in patients with multiple myeloma
暂无分享,去创建一个
M. Chiron | Haibo Sun | R. Rajalingam | T. Martin | S. Macé | J. Wolf | J. Venstrom | J. Marra | J. Keats | Denice Z. Kong